Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Blin

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Pharmacological Research|December 25, 2018
Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort studyPatrick Blin, Charles-Marc Samama, Alain Sautet, et al.
European Journal of Gastroenterology & Hepatology|October 23, 2010
High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patientsPatrick Marcellin, Jean-François Cadranel, Thierry Fontanges, et al.
Drug Safety|May 10, 2019
Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY StudyEstelle Guiard, Bénédicte Lelievre, Magali Rouyer, et al.
JBMR Plus|September 13, 2023
Real-World Effectiveness of Osteoporosis Medications in France: A Nationwide Cohort StudyPauline Bosco-Lévy, Karine Briot, Nadia Mehsen-Cetre, et al.
Pharmacoepidemiology and Drug Safety|March 6, 2020
Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE projectNicolas H Thurin, Régis Lassalle, Martijn Schuemie, et al.
Atherosclerosis|January 19, 2019
Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims databasePatrick Blin, Caroline Dureau-Pournin, Jacques Benichou, et al.
Clinical Drug Investigation|January 7, 2026
Therapeutic Strategies After Discontinuation of Valproate By Females with Epilepsy of Child-Bearing Potential: An Insurance Claims Database Study in France and the United KingdomSandrine Colas, Juliette Longin, Xinyu Li, et al.
Ophthalmic Research|April 1, 2019
Real-World Outcomes with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema: 12-Month Results from the 36-Month BOREAL-DME StudyPascale Massin, Catherine Creuzot-Garcher, Laurent Kodjikian, et al.
Ophthalmic Research|September 15, 2020
Real-World Outcomes after 36-Month Treatment with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema (BOREAL-DME)Pascale Massin, Catherine Creuzot-Garcher, Laurent Kodjikian, et al.
Pharmacoepidemiology and Drug Safety|June 12, 2020
Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS)Nicolas H Thurin, Régis Lassalle, Martijn Schuemie, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Pharmacological Research|December 25, 2018
Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort studyPatrick Blin, Charles-Marc Samama, Alain Sautet, et al.
European Journal of Gastroenterology & Hepatology|October 23, 2010
High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patientsPatrick Marcellin, Jean-François Cadranel, Thierry Fontanges, et al.
Drug Safety|May 10, 2019
Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY StudyEstelle Guiard, Bénédicte Lelievre, Magali Rouyer, et al.
JBMR Plus|September 13, 2023
Real-World Effectiveness of Osteoporosis Medications in France: A Nationwide Cohort StudyPauline Bosco-Lévy, Karine Briot, Nadia Mehsen-Cetre, et al.
Pharmacoepidemiology and Drug Safety|March 6, 2020
Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE projectNicolas H Thurin, Régis Lassalle, Martijn Schuemie, et al.
Atherosclerosis|January 19, 2019
Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims databasePatrick Blin, Caroline Dureau-Pournin, Jacques Benichou, et al.
Clinical Drug Investigation|January 7, 2026
Therapeutic Strategies After Discontinuation of Valproate By Females with Epilepsy of Child-Bearing Potential: An Insurance Claims Database Study in France and the United KingdomSandrine Colas, Juliette Longin, Xinyu Li, et al.
Ophthalmic Research|April 1, 2019
Real-World Outcomes with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema: 12-Month Results from the 36-Month BOREAL-DME StudyPascale Massin, Catherine Creuzot-Garcher, Laurent Kodjikian, et al.
Ophthalmic Research|September 15, 2020
Real-World Outcomes after 36-Month Treatment with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema (BOREAL-DME)Pascale Massin, Catherine Creuzot-Garcher, Laurent Kodjikian, et al.
Pharmacoepidemiology and Drug Safety|June 12, 2020
Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS)Nicolas H Thurin, Régis Lassalle, Martijn Schuemie, et al.
Pageof 10